Tomkiel Melissa M. 4

4 · Strata Critical Medical, Inc. · Filed Apr 27, 2026

AI-generated summary of this filing

Updated Apr 27, 2026

Strata (SRTA) Co-CEO Melissa Tomkiel Receives Award

What Happened

Melissa M. Tomkiel, Co-CEO, General Counsel and Director of Strata Critical Medical, received 630,264 shares on 2026-04-23 upon vesting of performance-based restricted stock units (PSUs). The grant is reported at $0 acquisition price (award).
On 2026-04-24, 321,750 of those shares were withheld by the company to satisfy tax withholding obligations at an implied value of $4.92 per share, totaling $1,583,010. Net shares delivered to Tomkiel after withholding: 308,514.
This sequence is an award/vesting plus issuer tax withholding (not an open-market sale by the insider).

Key Details

Transaction dates/prices: 4/23/2026 — Award of 630,264 shares at $0.00 (code A); 4/24/2026 — 321,750 shares withheld at $4.92/share (code F), proceeds/withholding = $1,583,010.
Shares owned after transaction: Not specified in the provided filing excerpt.
Footnotes: F1 — shares were issued upon Compensation Committee certification that performance criteria for PSUs (granted 3/20/2025) were met. F2 — shares were withheld by the issuer to satisfy tax withholding.
Filing timeliness: Form 4 filed 2026-04-27; filing covers 4/23 and 4/24 transactions and is timely (not marked late).

Context

PSUs are performance-based awards; the award reflects compensation vesting, not a market purchase. The withholding is a routine, issuer-handled tax payment (common in equity compensation).
For investors, awards indicate executive compensation realization but do not, by themselves, indicate buying or selling intent.

Form 4

Period: 2026-04-23

DirectorCo-CEO and General Counsel

Transactions

Award
Class A common stock, $0.0001 par value per share
[F1]
2026-04-23+630,264→ 2,244,254 total
Tax Payment
Class A common stock, $0.0001 par value per share
[F2]
2026-04-24$4.92/sh−321,750$1,583,010→ 1,922,504 total

Footnotes (2)

[F1]Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
[F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.

Signature

/s/ Melissa M. Tomkiel|2026-04-27

1 file